SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-011793
Filing Date
2018-02-28
Accepted
2018-02-28 16:32:02
Documents
101
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v485049_10k.htm 10-K 2173032
2 EXHIBIT 10.2.1 tv485049_ex10x2x1.htm EX-10.2.1 50503
3 EXHIBIT 10.8 tv485049_ex10-8.htm EX-10.8 82798
4 EXHIBIT 10.21 tv485049_ex10-21.htm EX-10.21 28222
5 EXHIBIT 12.1 v485049_exhx12x1.htm EX-12.1 10771
6 EXHIBIT 21.1 v485049_exhx21x1.htm EX-21.1 7476
7 EXHIBIT 23.1 v485049_exhx23x1.htm EX-23.1 4134
8 EXHIBIT 31.1 v485049_exhx31x1.htm EX-31.1 15395
9 EXHIBIT 31.2 v485049_exhx31x2.htm EX-31.2 15384
10 EXHIBIT 32 v485049_exhx32.htm EX-32 5659
17 GRAPHIC line.gif GRAPHIC 43
18 GRAPHIC spacer.gif GRAPHIC 43
19 GRAPHIC v485049_chrt-pipeline.jpg GRAPHIC 79829
20 GRAPHIC v485049_chrt-bar1.jpg GRAPHIC 137768
21 GRAPHIC v485049_chrt-bar2.jpg GRAPHIC 218135
22 GRAPHIC v485049_chrt-line.jpg GRAPHIC 221236
  Complete submission text file 0001144204-18-011793.txt   10563759

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE icpt-20171231.xml EX-101.INS 2484778
12 XBRL SCHEMA FILE icpt-20171231.xsd EX-101.SCH 52605
13 XBRL CALCULATION FILE icpt-20171231_cal.xml EX-101.CAL 73905
14 XBRL DEFINITION FILE icpt-20171231_def.xml EX-101.DEF 154901
15 XBRL LABEL FILE icpt-20171231_lab.xml EX-101.LAB 426164
16 XBRL PRESENTATION FILE icpt-20171231_pre.xml EX-101.PRE 383000
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35668 | Film No.: 18651729
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences